Atlas Trials

Aurinia Pharmaceuticals Inc.

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aurinia Pharmaceuticals Inc.

RecordFirmDate
Study of Aritinercept in Patients With Generalized Myasthenia Gravis (NCT07596901)Aurinia Pharmaceuticals Inc.2026-04-22
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis (NCT07611214)Aurinia Pharmaceuticals Inc.2026-04-22
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis (NCT05962788)Aurinia Pharmaceuticals Inc.2024-03-28
Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis (NCT05288855)Aurinia Pharmaceuticals Inc.2023-10-10
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US (NCT05337124)Aurinia Pharmaceuticals Inc.2022-04-05
Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin (NCT05306379)Aurinia Pharmaceuticals Inc.2022-01-24
Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome (NCT04147650)Aurinia Pharmaceuticals Inc.2019-10-14
Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin (NCT03597464)Aurinia Pharmaceuticals Inc.2019-09-29
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease (NCT03597139)Aurinia Pharmaceuticals Inc.2018-08-13
Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis (NCT03598036)Aurinia Pharmaceuticals Inc.2018-06-21

Track Aurinia Pharmaceuticals Inc. automatically

Every clearance here is in the API, with alerts when new ones post.